IBR Inc., Institute for Biopharmaceutical Research (IBR) is a Swiss GLP-compliant contract research organization founded in 1998. With a core competence in inflammation research IBR provides bioanalytical services for preclinical and clinical studies to biotechnology and pharmaceutical companies. The services encompass method development, validation and sample analyses covering drug characterization, mode-of-action, pharmacology and preclinical safety evaluation with a broad panel of bioanalytical and immunological methods, including cell based assays. With the profound background of a GLP-compliant test facility IBR develops tailored software modules dedicated to quality managed laboratories.